Applications of High-throughput DNA Sequencing to Benign Hematology

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2013 Sep 12

PMID 24021670

Citations 16

Authors

Vijay G Sankaran

Patrick G Gallagher

Affiliations

Soon will be listed here.

Abstract

The development of novel technologies for high-throughput DNA sequencing is having a major impact on our ability to measure and define normal and pathologic variation in humans. This review discusses advances in DNA sequencing that have been applied to benign hematologic disorders, including those affecting the red blood cell, the neutrophil, and other white blood cell lineages. Relevant examples of how these approaches have been used for disease diagnosis, gene discovery, and studying complex traits are provided. High-throughput DNA sequencing technology holds significant promise for impacting clinical care. This includes development of improved disease detection and diagnosis, better understanding of disease progression and stratification of risk of disease-specific complications, and development of improved therapeutic strategies, particularly patient-specific pharmacogenomics-based therapy, with monitoring of therapy by genomic biomarkers.

Citing Articles

LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study.

Liang H, Wang R, Cheng R, Ye Z, Zhao N, Zhao X Clin Transl Med. 2025; 15(1):e70160.

PMID: 39783847 PMC: 11714244. DOI: 10.1002/ctm2.70160.

Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism.

Feng H, Wu C, Zhong G, Gong J, Miao C, Xiong B J Cancer Res Clin Oncol. 2023; 149(17):15879-15898.

PMID: 37673823 DOI: 10.1007/s00432-023-05360-3.

Anemia in the pediatric patient.

Gallagher P Blood. 2022; 140(6):571-593.

PMID: 35213686 PMC: 9373018. DOI: 10.1182/blood.2020006479.

Diagnostic approaches for inherited hemolytic anemia in the genetic era.

Kim Y, Park J, Kim M Blood Res. 2017; 52(2):84-94.

PMID: 28698843 PMC: 5503903. DOI: 10.5045/br.2017.52.2.84.

Whole-exome sequencing identifies an α-globin cluster triplication resulting in increased clinical severity of β-thalassemia.

Steinberg-Shemer O, Ulirsch J, Noy-Lotan S, Krasnov T, Attias D, Dgany O Cold Spring Harb Mol Case Stud. 2017; 3(6).

PMID: 28667000 PMC: 5701307. DOI: 10.1101/mcs.a001941.

References

Pasquet M, Bellanne-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O . High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 2012; 121(5):822-9. PMC: 3714670. DOI: 10.1182/blood-2012-08-447367. View

Piton A, Redin C, Mandel J . XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet. 2013; 93(2):368-83. PMC: 3738825. DOI: 10.1016/j.ajhg.2013.06.013. View

Andolfo I, Alper S, De Franceschi L, Auriemma C, Russo R, De Falco L . Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood. 2013; 121(19):3925-35, S1-12. DOI: 10.1182/blood-2013-02-482489. View

Worthey E, Mayer A, Syverson G, Helbling D, Bonacci B, Decker B . Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2010; 13(3):255-62. DOI: 10.1097/GIM.0b013e3182088158. View

Zarychanski R, Schulz V, Houston B, Maksimova Y, Houston D, Smith B . Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis. Blood. 2012; 120(9):1908-15. PMC: 3448561. DOI: 10.1182/blood-2012-04-422253. View

Ballew B, Yeager M, Jacobs K, Giri N, Boland J, Burdett L . Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet. 2013; 132(4):473-80. PMC: 3600110. DOI: 10.1007/s00439-013-1265-8. View

Green R, Berg J, Grody W, Kalia S, Korf B, Martin C . ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013; 15(7):565-74. PMC: 3727274. DOI: 10.1038/gim.2013.73. View

Nelson M, Wegmann D, Ehm M, Kessner D, St Jean P, Verzilli C . An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science. 2012; 337(6090):100-4. PMC: 4319976. DOI: 10.1126/science.1217876. View

Kirby A, Gnirke A, Jaffe D, Baresova V, Pochet N, Blumenstiel B . Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013; 45(3):299-303. PMC: 3901305. DOI: 10.1038/ng.2543. View

10.

Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I . Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet. 2012; 57(10):621-32. DOI: 10.1038/jhg.2012.91. View

11.

Knies K, Schuster B, Ameziane N, Rooimans M, Bettecken T, de Winter J . Genotyping of fanconi anemia patients by whole exome sequencing: advantages and challenges. PLoS One. 2013; 7(12):e52648. PMC: 3527584. DOI: 10.1371/journal.pone.0052648. View

12.

Hsu A, Sampaio E, Khan J, Calvo K, Lemieux J, Patel S . Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood. 2011; 118(10):2653-5. PMC: 3172785. DOI: 10.1182/blood-2011-05-356352. View

13.

Cooper D, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H . Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013; 132(10):1077-130. PMC: 3778950. DOI: 10.1007/s00439-013-1331-2. View

14.

Cullinane A, Vilboux T, OBrien K, Curry J, Maynard D, Carlson-Donohoe H . Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia. J Invest Dermatol. 2011; 131(10):2017-25. PMC: 3174312. DOI: 10.1038/jid.2011.157. View

15.

Perutz M, Rossmann M, CULLIS A, MUIRHEAD H, WILL G, North A . Structure of haemoglobin: a three-dimensional Fourier synthesis at 5.5-A. resolution, obtained by X-ray analysis. Nature. 1960; 185(4711):416-22. DOI: 10.1038/185416a0. View

16.

McGuire A, Joffe S, Koenig B, Biesecker B, McCullough L, Blumenthal-Barby J . Point-counterpoint. Ethics and genomic incidental findings. Science. 2013; 340(6136):1047-8. PMC: 3772710. DOI: 10.1126/science.1240156. View

17.

Weiss M, Mason P, Bessler M . What's in a name?. J Clin Invest. 2012; 122(7):2346-9. PMC: 3386834. DOI: 10.1172/JCI63989. View

18.

Khuong-Quang D, Schwartzentruber J, Westerman M, Lepage P, Finberg K, Majewski J . Iron refractory iron deficiency anemia: presentation with hyperferritinemia and response to oral iron therapy. Pediatrics. 2013; 131(2):e620-5. PMC: 3675830. DOI: 10.1542/peds.2012-1303. View

19.

Ji W, Foo J, ORoak B, Zhao H, Larson M, Simon D . Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008; 40(5):592-599. PMC: 3766631. DOI: 10.1038/ng.118. View

20.

Mahaney M, Brugnara C, Lease L, Platt O . Genetic influences on peripheral blood cell counts: a study in baboons. Blood. 2005; 106(4):1210-4. PMC: 1895191. DOI: 10.1182/blood-2004-12-4863. View